DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

DRG Oncology Pulse

Stay on top of updates and innovations in the oncology landscape and how it impacts your decisions

CAR T-cell Therapies: Takeaways and Best Practices for Strategy Planning

View more

DRG Data in Japan Government Presentation

View more

Developments in Acute Myeloid Leukemia

View more
Ask us your question

Expanding Horizons in Advanced Breast Cancer

View more
Ask us your question

A timeline of key moments in the development of checkpoint inhibitors

View more

PARP Inhibitors Updates from ESMO 2018

View more

Libtayo's FDA Approval: What to Expect from this Novel PD-1 Inhibitor

View more

Oncology Marketing Perspectives

View more

Blood Cancer Awareness Month: Key Trends in the Hematology Oncology Market

View more